Michael B. Fowler, MB, FRCP

Clinical Focus

• Cardiology (Heart)
• Cardiovascular Medicine
• Heart and Lung Transplantation
• Heart Failure
• Cardiomyopathy

Administrative Appointments

• Medical Director, CardiomyopathyCenter, Stanford University Medical Center (2001 - present)
• Director, Heart Failure Program, Stanford University Medical Center (2001 - present)
• Professor of Medicine, CardiovascularMedicine, Stanford University Medical Center (1999 - present)
• Assoc. Prof. of Medicine, CardiovascularMedicine, Stanford University Medical Center (1993 - 1999)
• Co-Director, Heart Failure Clinic, Stanford University Medical Center (1991 - 2001)
View All 9administrative appointments of Michael Fowler

Professional Education

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information

Research Interests

Adrenergic nervous system; beta-adrenergic function in, heart failure; drugs in heart failure.

Clinical Trials

• Study of the Effect of Sitagliptin on Glucose (Sugar) Metabolism in Patients with Heart Failure Recruiting

Publications

• Worsening of Left Ventricular End-Systolic Volume and Mitral Regurgitation without Increase in Left Ventricular Dyssynchrony on Acute Interruption of Cardiac Resynchronization Therapy. Kuppahally SS, Fowler MB, Vagelos R, Wang P, Al-Ahmad A, Paloma A, Liang D. Echocardiography. 2009
• Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. Witteles RM, Fowler MB. J Am Coll Cardiol. 2008; 51 (2): 93-102
• Hypertension, heart failure, and beta-adrenergic blocking drugs. Fowler MB, J Am Coll Cardiol. 2008; 52 (13): 1073-5
• Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial. Witteles RM, Kao D, Christopherson D, Matsuda K, Vagelos RH, Schreiber D, Fowler MB. J Am Coll Cardiol. 2007; 50 (19): 1835-40
• The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators. Chen HA, Hsia HH, Vagelos R, Fowler M, Wang P, Al-Ahmad A. Pacing Clin Electrophysiol. 2007; 30 (3): 390-4